SenokotXTRA

Dosage form: tablet
Ingredients: SENNOSIDES 17.2mg
Labeler: Purdue Products LP
NDC code: 67618-315

Medically reviewed by Drugs.com. Last updated on Jan 26, 2024.

SenokotXTRA
(standardized senna concentrate)

Drug Facts

Active ingredient (in each tablet) Purpose

Sennosides 17.2 mg

Purpose

Laxative

Uses

relieves occasional constipation (irregularity)
generally causes bowel movement in 6-12 hours

Warnings

Do not use

laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have

stomach pain
nausea
vomiting
noticed a sudden change in bowel movements that continues over a period of 2 weeks

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

take preferably at bedtime or as directed by a doctor

age	starting dosage	maximum dosage
adults and children 12 years of age and over	1 tablet once a day	2 tablets twice a day
children 6 to under 12 years	1/2 tablet once a day	1 tablet twice a day
children under 6	ask a doctor	ask a doctor

Other information

each tablet contains: calcium 20 mg
store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F)

Inactive ingredients croscarmellose sodium, dicalcium phosphate, hypromellose, lactose, magnesium stearate, microcrystalline cellulose, mineral oil, stearic acid, talc, tartaric acid

Dist. by: Purdue Products L.P., Stamford, CT 06901-3431

302602-0A

SenokotXTRA

12 Tablets

SENOKOTXTRA
standardized senna concentrate tablet

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:67618-315
Route of Administration	ORAL	DEA Schedule

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SENNOSIDES (SENNOSIDES)	SENNOSIDES	17.2 mg

Inactive Ingredients
Ingredient Name	Strength
croscarmellose sodium
anhydrous lactose
magnesium stearate
cellulose, microcrystalline
mineral oil
stearic acid
tartaric acid
hypromelloses
anhydrous dibasic calcium phosphate

Product Characteristics
Color	BROWN (Light Brown)	Score	no score
Shape	ROUND	Size	9mm
Flavor		Imprint Code	X
Contains

Packaging
#	Item Code	Package Description
1	NDC:67618-315-12	1 BLISTER PACK in 1 CARTON
1		12 TABLET in 1 BLISTER PACK
2	NDC:67618-315-36	3 BLISTER PACK in 1 CARTON
2		12 TABLET in 1 BLISTER PACK

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph not final	part334	09/01/1988

Labeler - Purdue Products LP (141916531)

Registrant - Purdue Pharma LP (932323652)

Establishment
Name	Address	ID/FEI	Operations
Contract Pharmacal Corporation		968334974	MANUFACTURE(67618-315)

Revised: 02/2014

Document Id: 08e1a2f2-be14-95ba-f1ae-f7744e8af835

Set id: f27cb405-9820-4fe9-8432-e50643f2c7f0

Version: 2

Effective Time: 20140205

Purdue Products LP

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer